Breamy: An augmented reality mHealth prototype for surgical decision-making in breast cancer.
Niki NajafiMiranda AddieSarkis MeterissianMarta Kersten-OertelPublished in: Healthcare technology letters (2023)
Breast cancer is one of the most prevalent forms of cancer, affecting approximately one in eight women during their lifetime. Deciding on breast cancer treatment, which includes the choice between surgical options, frequently demands prompt decision-making within an 8-week timeframe. However, many women lack the necessary knowledge and preparation for making informed decisions. Anxiety and unsatisfactory outcomes can result from inadequate decision-making processes, leading to decisional regret and revision surgeries. Shared decision-making and personalized decision aids have shown positive effects on patient satisfaction and treatment outcomes. Here, Breamy, a prototype mobile health application that utilizes augmented reality technology to assist breast cancer patients in making more informed decisions is introduced. Breamy provides 3D visualizations of different surgical procedures, aiming to improve confidence in surgical decision-making, reduce decisional regret, and enhance patient well-being after surgery. To determine the perception of the usefulness of Breamy, data was collected from 166 participants through an online survey. The results suggest that Breamy has the potential to reduce patients' anxiety levels and assist them in decision-making.
Keyphrases
- decision making
- patient satisfaction
- end stage renal disease
- polycystic ovary syndrome
- ejection fraction
- healthcare
- chronic kidney disease
- breast cancer risk
- sleep quality
- virtual reality
- total knee arthroplasty
- clinical trial
- cross sectional
- papillary thyroid
- mass spectrometry
- metabolic syndrome
- electronic health record
- depressive symptoms
- young adults
- pregnant women
- machine learning
- big data
- patient reported outcomes
- prognostic factors
- liquid chromatography
- antiretroviral therapy
- physical activity
- cervical cancer screening